Solmaz, SonerGokgoz, ZaferGereklioglu, CigdemYeral, MahmutBoga, CanOzdogu, Hakan2023-05-312023-05-3120171304-0855http://hdl.handle.net/11727/9298New-onset diabetes mellitus after solid-organ transplant makes for complicated tacrolimus immuno suppression. However, tacrolimus-associated diabetic ketoacidosis has not been reported in bone marrow transplant. We report 24-year-old women, hospitalized with diabetic ketoacidosis, 70 days after undergoing a bone marrow transplant with tacrolimus immunosuppression. Clinicians should be wary about tacrolimus levels and the risk of hyperglycemic states after bone marrow transplant as with other solid-organ transplants.enginfo:eu-repo/semantics/closedAccessAcute leukemiaDiabetic ketoacidosisTacrolimusarticle1567027030004194601000212-s2.0-85038808839